1. Pathogenic lipid‐binding antiphospholipid antibodies are associated with severity of COVID‐19. (22nd July 2021) Authors: Hollerbach, Anne; Müller‐Calleja, Nadine; Pedrosa, Denise; Canisius, Antje; Sprinzl, Martin F.; Falter, Tanja; Rossmann, Heidi; Bodenstein, Marc; Werner, Christian; Sagoschen, Ingo; Münzel, Thomas; Schreiner, Oliver; Sivanathan, Visvakanth; Reuter, Michael; Niermann, Johannes; Galle, Peter R.; Te... Journal: Journal of thrombosis and haemostasis Issue: Volume 19:Number 9(2021) Page Start: 2335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study. Issue 1 (8th December 2021) Authors: Kremer, Wolfgang M.; Labenz, Christian; Kuchen, Robert; Sagoschen, Ingo; Bodenstein, Marc; Schreiner, Oliver; Wörns, Marcus A.; Sivanathan, Visvakanth; Weinmann, Arndt; Galle, Peter R.; Sprinzl, Martin F. Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 13:Issue 1(2022) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report. Issue 12 (15th September 2020) Authors: Kaps, Leonard; Labenz, Christian; Grimm, Daniel; Schwarting, Andreas; Galle, Peter R.; Schreiner, Oliver Journal: Clinical case reports Issue: Volume 8:Issue 12(2020) Page Start: 2989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗